Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: ...
As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive disorders, and also cancer. Researchers at the German Institute of Human ...
Late diagnosis and ineffective therapeutic options mean that pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer. The identification of genetic alterations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback